Literature DB >> 17503116

Fatigue in neuroimmunological diseases.

Brigitte Greim1, Claudia Engel, Annett Apel, Uwe K Zettl.   

Abstract

Fatigue is a widespread symptom in numerous neuroimmunological diseases like multiple sclerosis (MS), myasthenia gravis, morbus Behcet, neurosarcoidosis, neuroborreliosis or immune vasculitis. This phenomenon is best investigated in MS. The complex mechanisms underlying fatigue in MS are still poorly understood; alterations in immune system activation, central nervous system dysregulation, impaired nerve conduction, and neuroendocrine dysregulation have to be considered. These immune and neural mechanisms may cause the initial symptoms of fatigue; however, the fatigue symptom may be exacerbated by secondary overlapping factors (e. g. depressive mood, sleep disturbances, unhealthy life style) which are likely associated with the feeling of fatigue. Wessely conceptualised four components of fatigue: behaviour (effects of fatigue), feeling (subjective experience), mechanisms, and context (e. g. environment, attitudes). So far most examinations have dealt with the first or the second component of the multidimensional construct fatigue, either concentrating on the behavioural aspect in the physical or in the cognitive sphere or on the subjective aspect. The Rostock Fatigue Study investigated two of the components: objective performance and subjective fatigue estimation in the cognitive and in the physical sphere. MS patients showed a reversed relationship between below-average objective performance in the cognitive and in the physical sphere and high subjective feeling of tiredness when compared to healthy individuals. The clinical management of fatigue should include an assessment of the various factors that can cause fatigue as well as a step-wise treatment approach that encompasses nonpharmacological approaches and pharmacological interventions.

Entities:  

Mesh:

Year:  2007        PMID: 17503116     DOI: 10.1007/s00415-007-2025-2

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  20 in total

Review 1.  Chronic fatigue syndrome--aetiological aspects.

Authors:  C J Dickinson
Journal:  Eur J Clin Invest       Date:  1997-04       Impact factor: 4.686

Review 2.  Multiple sclerosis-related fatigue.

Authors:  William S MacAllister; Lauren B Krupp
Journal:  Phys Med Rehabil Clin N Am       Date:  2005-05       Impact factor: 1.784

3.  Identification of Beck Depression Inventory items related to multiple sclerosis.

Authors:  D C Mohr; D E Goodkin; W Likosky; L Beutler; N Gatto; M K Langan
Journal:  J Behav Med       Date:  1997-08

4.  Fatigue in progressive multiple sclerosis: results of a randomized, double-blind, placebo-controlled, crossover trial of oral 4-aminopyridine.

Authors:  P M Rossini; P Pasqualetti; C Pozzilli; M G Grasso; E Millefiorini; A Graceffa; G A Carlesimo; G Zibellini; C Caltagirone
Journal:  Mult Scler       Date:  2001-12       Impact factor: 6.312

5.  Fatigue in multiple sclerosis.

Authors:  L B Krupp; L A Alvarez; N G LaRocca; L C Scheinberg
Journal:  Arch Neurol       Date:  1988-04

6.  Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study.

Authors:  B Stankoff; E Waubant; C Confavreux; G Edan; M Debouverie; L Rumbach; T Moreau; J Pelletier; C Lubetzki; M Clanet
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

7.  Quantitative assessment of motor fatigue and strength in MS.

Authors:  S R Schwid; C A Thornton; S Pandya; K L Manzur; M Sanjak; M D Petrie; M P McDermott; A D Goodman
Journal:  Neurology       Date:  1999-09-11       Impact factor: 9.910

8.  The effect of immunomodulatory treatment on multiple sclerosis fatigue.

Authors:  L M Metz; S B Patten; C J Archibald; J I Bakker; C J Harris; D G Patry; R B Bell; M Yeung; W F Murphy; C A Stoian; K Billesberger; L Tillotson; S Peters; D McGowan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-07       Impact factor: 10.154

Review 9.  Fatigue associated with multiple sclerosis: diagnosis, impact and management.

Authors:  Rohit Bakshi
Journal:  Mult Scler       Date:  2003-06       Impact factor: 6.312

10.  Cognitive fatigue during a test requiring sustained attention: a pilot study.

Authors:  Steven R Schwid; Carolyn M Tyler; Eileen A Scheid; Amy Weinstein; Andrew D Goodman; Michael P McDermott
Journal:  Mult Scler       Date:  2003-10       Impact factor: 6.312

View more
  4 in total

1.  Hypoxemia, Sleep Disturbances, and Depression Correlated with Fatigue in Neuromyelitis Optica Spectrum Disorder.

Authors:  Jing Pan; Peng Zhao; Hao Cai; Lei Su; Kristofer Wood; Fu-Dong Shi; Ying Fu
Journal:  CNS Neurosci Ther       Date:  2015-06-01       Impact factor: 5.243

Review 2.  Cognitive impairment in multiple sclerosis.

Authors:  Alexander Winkelmann; Claudia Engel; Annett Apel; Uwe K Zettl
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

3.  Fatigue in patients with neuromyelitis optica spectrum disorder and its impact on quality of life.

Authors:  Jin Myoung Seok; Misong Choi; Eun Bin Cho; Hye Lim Lee; Byoung Joon Kim; Kwang Ho Lee; Pamela Song; Eun Yeon Joo; Ju-Hong Min
Journal:  PLoS One       Date:  2017-05-23       Impact factor: 3.240

Review 4.  The pathophysiology of motor fatigue and fatigability in multiple sclerosis.

Authors:  Robert Patejdl; Uwe K Zettl
Journal:  Front Neurol       Date:  2022-07-27       Impact factor: 4.086

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.